Thyrocare Technologies Ltd.

View in App
468.10 -4.70 ▼-1.0%

09 June 2023, 04:01:00 PM
Volume: 1,182

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.thyrocare.com
Market Cap 2,487.71 Cr.
Enterprise Value(EV) 2,459.24 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 12.18 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 38.42 Trailing Twelve Months Ending 2023-03
Industry PE 49.44 Trailing Twelve Months Ending 2023-03
Book Value / Share 100.94 Trailing Twelve Months Ending 2023-03
Price to Book Value 4.64 Calculated using Price: 468.10
Dividend Yield 3.19 Period Ending 2022-03
No. of Shares Subscribed 5.29 Cr. 52,930,043 Shares
FaceValue 10
About Thyrocare Technologies Ltd.
Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively.

Thyrocare Technologies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Thyrocare Technologies Ltd. Performance

View details >>
1 Day
-0.99%
1 Week
-3.27%
1 Month
+1.56%
3 Month
-1.02%
6 Month
-24.45%
1 Year
-31.70%
2 Year
-56.27%
5 Year
-21.45%
10 Year

Thyrocare Technologies Ltd. Fundamental Ratios

View details >>
8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.98 16.22 11.20 22.16 19.41 22.13 28.75 37.18
Return on Capital Employed (%) 24.57 25.66 21.05 33.93 31.36 35.14 38.51 48.24
Return on Assets (%) 13.41 14.09 10.20 20.59 17.93 18.73 22.43 30.87

Thyrocare Technologies Ltd. Balance Sheet

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 276 366 408 443 435 367 427 527 534
Non Curr. Liab. 9 10 9 10 14 21 18 10 8
Curr. Liab. 7 31 18 20 21 82 95 65 77
Minority Int. 36 1
Equity & Liab. 328 407 434 474 470 469 540 601 620
Non Curr. Assets 218 273 285 332 334 317 300 331 348
Curr. Assets 111 134 150 142 136 152 240 270 273
Misc. Exp. not W/O
Total Assets 328 407 434 474 470 469 540 601 620

Thyrocare Technologies Ltd. Profit and Loss

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 183 241 304 356 403 434 495 589 527
Other Income 8 7 12 23 10 7 12 29 8
Total Income 191 248 317 380 413 441 507 618 535
Total Expenditure -110 -147 -189 -212 -249 -261 -323 -354 -407
PBIDT 81 101 128 168 164 180 184 264 128
Interest 0 -1 0 0 -1 -2 -1 -2 -2
Depreciation -13 -18 -18 -20 -26 -32 -30 -34 -39
Taxation -24 -30 -39 -52 -53 -52 -39 -52 -24
Exceptional Items -27 -2 -7
PAT 44 52 43 93 85 88 113 176 63
Minority Interest 1 0
Share Associate 1 1 1
Other Related Items 0 -1 0
Consolidated Net Profit 45 52 43 93 85 89 112 176 64
Adjusted EPS 9 10 8 17 16 17 21 33 12

Thyrocare Technologies Ltd. Cash Flow

View details >>
Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 68 90 107 100 168 115 113
Cash Fr. Inv. -18 -18 -42 -43 -12 1 -49 -24
Cash Fr. Finan. -23 -45 -49 -64 -94 -165 -62 -89
Net Change -6 5 0 0 -5 4 4 0
Cash & Cash Eqvt 5 10 10 10 5 9 13 14

Thyrocare Technologies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 66.14 66.14 71.22 71.18 71.18 71.18 71.14 71.14 71.14
Public 33.86 33.86 28.78 28.82 28.82 28.82 28.86 28.86 28.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Thyrocare Technologies Ltd. Announcements

View details >>
Thu, 08 Jun 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nippon Life India Trustee Ltd
Sat, 03 Jun 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Meeting with Investors/Analysts
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the Listing Regulation read with SEBI circular no CIR/CFD/CMD1/27/2019 dated February 8 2019 BSE Notice No. 20230316-14 and NSE Circular Ref No: NSE/CML/2023/21 both dated March 16 2023 please find enclosed herewith Annual Secretarial Compliance Report for the financial year ended March 31 2023 issued by V Suresh Associates Secretarial Auditors of the Company.

Thyrocare Technologies Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
S Closing Below Previous Low for 2 Days
S Making Lower Lows for 2 Days

Thyrocare Technologies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Thyrocare Technologies Ltd. FAQ's

What is Thyrocare Tech. share price?
Can I buy Thyrocare Tech. shares now?
What is the Dividend Yield of Thyrocare Tech.?
What is the Market Cap of Thyrocare Tech.?
What are the key metrics to analyse Thyrocare Tech.?
What is the 52 Week High and Low of Thyrocare Tech.?
What is the trend of Thyrocare Tech. share price?